Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Biocept's Target Selector outperforms traditional tumor cell detection test in metastatic lung cancer study

% of readers think this story is Fact. Add your two cents.


Biocept Inc (NASDAQ:BIOC) announced promising results Monday from a prospective study of its Target Selector cerebrospinal fluid (CSF) testing in patients with non-small cell lung cancer (NSCLC) and leptomeningeal metastasis.

The study, which was presented virtually on Friday at the International Association for the Study of Lung Cancer, compared Biocept’s technology with traditional cytology (read: examining cells under a microscope). 

Specifically, the study looked at 28 CSF samples from 15 patients obtained before and during treatment for leptomeningeal metastasis, which occurs when cancer cells migrate to the body’s CSF.

READ: Biocept wins Japanese patent for its Primer-Switch technology to detect rare mutations and cancer biomarkers

Biocept’s Target selector found circulating tumor cells (CTCs) in 78% of samples, while cytology detected CTCs in 55% of samples. Target Selector also provided sensitive quantitative identification of actionable EGFR mutations, or damage to the DNA in a cancer cell, in cerebrospinal fluid.

The presentation, titled “Hot Topic: Liquid Biopsy” was given by David Berz, an oncologist at Beverly Hills Cancer Center. 

“Even in this small study, the ability to detect response to this experimental treatment in cerebrospinal fluid using Target Selector is promising, particularly as the diagnosis of leptomeningeal disease remains challenging using current methods,” Berz said in a statement. “Cytological assessment has limited sensitivity and often requires multiple sample collection attempts. In addition, cytology is a qualitative measurement, whereas Target Selector allows for quantitative assessment of treatment response. Given these encouraging results, additional studies of the use of Target Selector testing in patients with leptomeningeal disease is highly warranted.”

Ultimately, the goal is to help physicians make better-informed decisions about patients’ treatment.

“These results indicate Target Selector may play an important role in providing valuable information to neuro-oncologists in making treatment decisions for patients with lung cancer metastases to the brain,” CEO Michael Nall said. “As more therapies are developed with the ability to cross the blood brain barrier that target specific cancer related gene and protein alterations, analysis of cerebrospinal fluid to inform early detection and subsequent monitoring for treatment response and disease progression will likely become increasingly important.”

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Story by ProactiveInvestors



Source: https://www.proactiveinvestors.com/companies/news/930683/biocept-s-target-selector-outperforms-traditional-tumor-cell-detection-test-in-metastatic-lung-cancer-study-930683.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST


Order by Phone at 888-809-8385 or online at https://www.herbanomic.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...
Loading...

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.